Cancer Biology and Medicine 
Journal Title
- Cancer Biology and Medicine
ISSN
- P 2095-3941 | 2095-3941
Publisher
- Chinese Anticancer Association
Listed on(Coverage)
| JCR | 2017-2019 |
|---|---|
| SJR | 2013-2019 |
| CiteScore | 2013-2019 |
| SCIE | 2017-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2021 |
| DOAJ | 2019-2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | cancer genetics, oncology clinical trials, targeted therapy and immunology, cancer and stem cell biology, cancer prevention and epidemiology, cancer biomarkers |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY-NC |
| Copyrights | Yes |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- CHINA
Aime & Scopes
- Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: /// Cancer genetics /// Cancer and stem call biology /// Molecular and clinical immunology /// Cancer prevention and epidemiology /// Cancer biomarkers /// Radiation oncology /// Oncology clinical trials /// Mechanisms of drug sensitivity and resistance /// Targeted therapy and immunotherapy /// Multidisciplinary treatment and personalized medicine The journal adheres to the Uniform Requirements for Manuscripts Submitted to Biomedcal Journals, issued by the International Committee for Medical Journal Editors (ICMJE) and the guidelines of CommiĴ ee on Publication Ethics (COPE).